Outcomes with “Off the Shelf” Allogeneic CD19 Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies: A Systematic Review and Meta-Analysis

Background: Chimeric antigen receptor T cell (CAR-T) therapy is an adoptive T cell immunotherapy that employs the genetically modified T cell to attack the cancer cell. It is widely studied across various hematological and solid organ malignancies. Several autologous CD19 CAR-T cell therapy construc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2021-11, Vol.138 (Supplement 1), p.4831-4831
Hauptverfasser: Mushtaq, Muhammad Umair, Shahzad, Moazzam, Hussain, Ali, Shah, Amna Y, Siddiqui, Raheel S, Faisal, Muhammad Salman, Anwar, Iqra, Chaudhary, Sibgha Gull, Mohyuddin, Ghulam Rehman, Balusu, Ramesh, Tun, Aung M, Bansal, Rajat, Abdelhakim, Haitham, Hoffmann, Marc, Singh, Anurag K., Shune, Leyla, Abhyankar, Sunil, McGuirk, Joseph P., Ahmed, Nausheen
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!